MedPath

CHROMIUM

CHROMIUM Chromic Chloride Injection, USP 40 mcg/10 mL (4 mcg/mL)

Approved
Approval ID

b4d01ebb-a36e-44b7-028c-43c0ab2d13b4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 28, 2021

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CHROMIC CHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-4093
Application NumberNDA018961
Product Classification
M
Marketing Category
C73594
G
Generic Name
CHROMIC CHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 28, 2021
FDA Product Classification

INGREDIENTS (4)

SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
CHROMIC CHLORIDEActive
Quantity: 4 ug in 1 mL
Code: KB1PCR9DMW
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CHROMIUM - FDA Drug Approval Details